Health Care [ 11/12 ] | Health Care Equipment & Supplies [ 48/74 ]
NASDAQ | Common Stock
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.
The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 23 | -0.81 Decreased by -102.50% | -1.00 Increased by +19.00% |
| Aug 2, 23 | -0.05 Increased by +75.00% | -0.09 Increased by +44.44% |
| May 2, 23 | -0.12 Increased by +68.42% | -0.11 Decreased by -9.09% |
| Mar 22, 23 | -0.20 Increased by +23.08% | -0.21 Increased by +4.76% |
| Nov 14, 22 | -0.40 Decreased by -108.21% | -0.28 Decreased by -42.86% |
| Aug 9, 22 | -0.20 Increased by +65.87% | -0.34 Increased by +41.18% |
| May 11, 22 | -0.38 Increased by +57.94% | -0.31 Decreased by -22.58% |
| Mar 8, 22 | -0.26 Increased by +87.69% | -0.29 Increased by +10.34% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 11.96 M Decreased by -4.95% | -7.18 M Increased by +40.90% | Decreased by -60.02% Increased by +37.82% |
| Jun 30, 23 | 13.39 M Increased by +3.27% | -8.68 M Decreased by -37.21% | Decreased by -64.83% Decreased by -32.86% |
| Mar 31, 23 | 12.53 M Increased by +14.61% | -13.44 M Decreased by -16.40% | Decreased by -107.27% Decreased by -1.56% |
| Dec 31, 22 | 13.80 M Increased by +1.17% | -6.25 M Decreased by -157.78% | Decreased by -45.24% Decreased by -157.12% |
| Sep 30, 22 | 12.59 M Increased by +0.66% | -12.15 M Decreased by -276.74% | Decreased by -96.52% Decreased by -274.29% |
| Jun 30, 22 | 12.97 M Decreased by -8.13% | -6.33 M Increased by +55.12% | Decreased by -48.79% Increased by +51.15% |
| Mar 31, 22 | 10.94 M Decreased by -7.63% | -11.55 M Increased by +22.73% | Decreased by -105.62% Increased by +16.35% |
| Dec 31, 21 | 13.64 M Increased by +0.71% | 10.81 M Increased by +269.64% | Increased by +79.21% Increased by +268.45% |